Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harper G Hubbeling

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Therapeutic Advances in Hematology|April 5, 2013
Myelofibrosis 2012: it's complicatedHarper G Hubbeling, Dale M Frank, Elizabeth O Hexner
Cell Reports|December 9, 2014
Regulatory T cells occupy an isolated niche in the intestine that is antigen independentLisa L Korn, Harper G Hubbeling, Paige M Porrett, et al.
Nature Immunology|July 5, 2011
The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytesRichard N Hanna, Leo M Carlin, Harper G Hubbeling, et al.
Plos One|May 23, 2018
Psychosocial needs of young breast cancer survivors in Mexico City, MexicoHarper G Hubbeling, Shoshana M Rosenberg, Maria Cecilia González-Robledo, et al.
Circulation Research|December 24, 2011
NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosisRichard N Hanna, Iftach Shaked, Harper G Hubbeling, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 30, 2018
Safety of Combined PD-1 Pathway Inhibition and Intracranial Radiation Therapy in Non-Small Cell Lung CancerHarper G Hubbeling, Emily F Schapira, Nora K Horick, et al.
JCO Precision Oncology|January 16, 2018
Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in <i>ROS1</i>-Positive Non-Small-Cell Lung CancerJustin F Gainor, Diane Tseng, Satoshi Yoda, et al.
The Oncologist|February 15, 2026
Outcomes after SRS and Ipilimumab plus Nivolumab for Melanoma Brain Metastases Following Prior Immune Checkpoint Inhibitor or Targeted TherapyIan Messing, Lauren Linkowski, Matthew D Riina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2021
Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in <i>ROS1</i> Fusion-Positive Lung CancerJessica J Lin, Noura J Choudhury, Satoshi Yoda, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Therapeutic Advances in Hematology|April 5, 2013
Myelofibrosis 2012: it's complicatedHarper G Hubbeling, Dale M Frank, Elizabeth O Hexner
Cell Reports|December 9, 2014
Regulatory T cells occupy an isolated niche in the intestine that is antigen independentLisa L Korn, Harper G Hubbeling, Paige M Porrett, et al.
Nature Immunology|July 5, 2011
The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytesRichard N Hanna, Leo M Carlin, Harper G Hubbeling, et al.
Plos One|May 23, 2018
Psychosocial needs of young breast cancer survivors in Mexico City, MexicoHarper G Hubbeling, Shoshana M Rosenberg, Maria Cecilia González-Robledo, et al.
Circulation Research|December 24, 2011
NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosisRichard N Hanna, Iftach Shaked, Harper G Hubbeling, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 30, 2018
Safety of Combined PD-1 Pathway Inhibition and Intracranial Radiation Therapy in Non-Small Cell Lung CancerHarper G Hubbeling, Emily F Schapira, Nora K Horick, et al.
JCO Precision Oncology|January 16, 2018
Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in <i>ROS1</i>-Positive Non-Small-Cell Lung CancerJustin F Gainor, Diane Tseng, Satoshi Yoda, et al.
The Oncologist|February 15, 2026
Outcomes after SRS and Ipilimumab plus Nivolumab for Melanoma Brain Metastases Following Prior Immune Checkpoint Inhibitor or Targeted TherapyIan Messing, Lauren Linkowski, Matthew D Riina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2021
Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in <i>ROS1</i> Fusion-Positive Lung CancerJessica J Lin, Noura J Choudhury, Satoshi Yoda, et al.
Pageof 1